Omalizumab in persistent severe bakers' asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 6, 2008, Pages 790-791

  Olivieri, M ^a   Biscardo, C A ^b   Turri, S ^b   Perbellini, L ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b NONE

Author keywords

ACT; Bakers' asthma; Omalizumab; QoL

Indexed keywords

AMYLASE; FLUTICASONE; HISTAMINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; MONTELUKAST; OMALIZUMAB; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; HUMAN; INFORMED CONSENT; OCCUPATIONAL EXPOSURE; PRICK TEST; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT ALLERGY; SKIN TINGLING; TREATMENT DURATION; TREATMENT OUTCOME;

ALLERGENS; ANTIBODIES, MONOCLONAL; ASTHMA; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; SKIN TESTS; WHEAT HYPERSENSITIVITY;

EID: 42549109656     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01702.x     Document Type: Article

References (6)

1. Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF et al. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy 2004 34 : 632 638.
2. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005 60 : 309 316.
3. Bousquet T, Clark JH, Hurd S, Khaltaev N, Lenfant C, O'Byrne P et al. GINA guidelines on asthma and beyond. Allergy 2007 62 : 102 112.
4. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004 113 : 59 65.
5. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993 147 : 832 838.
6. Brown R, Turk F, Dale P, Bousquet J. Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy 2007 62 : 149 153.